These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10687670)

  • 21. [Management of arrhythmias in patients with heart failure].
    Le Heuzey JY; Copie X; Piot O; Lavergne T; Henry P; Guize L
    Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1371-6. PubMed ID: 9864606
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NHLBI stops arrhythmia study: implantable cardiac defibrillators reduce deaths.
    Circulation; 1997 Jun; 95(11):2465. PubMed ID: 9184572
    [No Abstract]   [Full Text] [Related]  

  • 23. Role of antiarrhythmic drugs in patients with implantable cardioverter defibrillators.
    Van Herendael H; Pinter A; Ahmad K; Korley V; Mangat I; Dorian P
    Europace; 2010 May; 12(5):618-25. PubMed ID: 20304841
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Statistical problems in the design of antiarrhythmic drug trials.
    Friedman LM; Schron EB
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S114-8. PubMed ID: 1279303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Role of antiarrhythmic drugs in reducing the number of defibrillation shocks].
    Deharo JC; Mouliom F; Salamand A; Djiane P
    Arch Mal Coeur Vaiss; 2005 Feb; 98(2):140-4. PubMed ID: 15787306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Overview of implantable cardioverter-defibrillator in reducing total mortality in the high-risk coronary patient.
    Mower MM
    Md Med J; 1997 Feb; 46(2):75-8. PubMed ID: 9029905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The year in review of clinical cardiac electrophysiology.
    Scheinman MM; Keung E
    J Am Coll Cardiol; 2008 May; 51(21):2075-81. PubMed ID: 18498966
    [No Abstract]   [Full Text] [Related]  

  • 28. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
    Pathmanathan RK; Lau EW; Cooper J; Newton L; Skehan JD; Garratt CJ; Griffith MJ
    Heart; 1998 Jul; 80(1):68-70. PubMed ID: 9764063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
    Laurenzi F; Avella A; Adinolfi E; Dini P
    G Ital Cardiol; 1999 Oct; 29(10):1190-4. PubMed ID: 10546132
    [No Abstract]   [Full Text] [Related]  

  • 30. [New fields of research in pharmacological antiarrhythmic therapy].
    Hatem S
    Arch Mal Coeur Vaiss; 2004 Nov; 97(11):1054-7. PubMed ID: 15609906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on arrhythmias and cardiac pacing 2013.
    Almendral J; Pombo M; Martínez-Alday J; González-Rebollo JM; Rodríguez-Font E; Martínez-Ferrer J; Castellanos E; García-Fernández FJ; Ruiz-Mateas F
    Rev Esp Cardiol (Engl Ed); 2014 Apr; 67(4):294-304. PubMed ID: 24774592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inductionless or limited shock testing is possible in most patients with implantable cardioverter- defibrillators/cardiac resynchronization therapy defibrillators: results of the multicenter ASSURE Study (Arrhythmia Single Shock Defibrillation Threshold Testing Versus Upper Limit of Vulnerability: Risk Reduction Evaluation With Implantable Cardioverter-Defibrillator Implantations).
    Day JD; Doshi RN; Belott P; Birgersdotter-Green U; Behboodikhah M; Ott P; Glatter KA; Tobias S; Frumin H; Lee BK; Merillat J; Wiener I; Wang S; Grogin H; Chun S; Patrawalla R; Crandall B; Osborn JS; Weiss JP; Lappe DL; Neuman S
    Circulation; 2007 May; 115(18):2382-9. PubMed ID: 17470697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Year in Cardiology 2012: arrhythmia and pacing.
    Garratt CJ; Saeed Y
    Eur Heart J; 2013 Feb; 34(5):333-7. PubMed ID: 23284092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Some features of cardiac arrythmia treatment in outpatient practice].
    Nedostup AV
    Ter Arkh; 2006; 78(8):5-13. PubMed ID: 17078210
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical evaluation of new anti-arrhythmia drugs after the CAST (Cardiac Arrhythmia Suppression Trial) study].
    Meinertz T; Zehender M; Hohnloser SH
    Z Kardiol; 1992; 81 Suppl 4():145-9. PubMed ID: 1290291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Variables of arrhythmia risk in relation to pacemaker and implantable defibrillator].
    Solano A; Oddone D; Croci F; Donateo P; Puggioni E; Brignole M
    Ital Heart J Suppl; 2001 Dec; 2(12):1303-7. PubMed ID: 11838352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of cardiac arrhythmia.
    Grace A
    Clin Med (Lond); 2008 Apr; 8(2):175-6. PubMed ID: 18478865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Critical care trial design and interpretation: a primer.
    Sevransky JE; Checkley W; Martin GS
    Crit Care Med; 2010 Sep; 38(9):1882-9. PubMed ID: 20639755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How reliable are clinical trials? The importance of the criteria for early termination.
    Schwartz PJ
    Eur Heart J; 1995 Aug; 16 Suppl G():37-45. PubMed ID: 8595799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interpreting the results of a clinical trial.
    Keech AC; Pike R; Granger RE; Gebski VJ
    Med J Aust; 2007 Mar; 186(6):318-9. PubMed ID: 17371216
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.